{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:06:56Z","timestamp":1790896016822,"version":"4.1.0"},"reference-count":123,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Breathe"],"accepted":{"date-parts":[[2025,4,25]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Lung cancer is the leading cause of cancer-related mortality worldwide, with nonsmall cell lung cancer (NSCLC) accounting for the majority of cases. Despite advancements in therapeutics, outcomes remain poor due to late-stage diagnoses and the molecular complexity of the disease. Liquid biopsy, a minimally invasive diagnostic approach, has emerged as a potentially transformative tool in lung cancer. The detection of tumour-derived biomarkers, such as circulating-tumour DNA, circulating tumour cells and exosomes, can be analysed for molecular profiling, early detection and monitoring of disease progression. There have been significant advancements of liquid biopsy technologies, such as next-generation sequencing and droplet digital PCR, that identify actionable mutations, detect resistance mechanisms and improve therapeutic outcomes. While there are still challenges like detecting early-stage disease and the risk of false positives, the combination of multi-omics data and artificial intelligence has the potential for more personalised and precise cancer treatments. Liquid biopsy represents a paradigm shift in the early detection and personalised treatment of lung cancer, offering significant potential to improve patient outcomes.<\/jats:p>","DOI":"10.1183\/20734735.0051-2025","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T08:30:19Z","timestamp":1755592219000},"page":"250051","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Liquid biopsy in lung cancer"],"prefix":"10.1183","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8634-7992","authenticated-orcid":false,"given":"Sile","family":"Toland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8293-455X","authenticated-orcid":false,"given":"Padraic","family":"Ridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmet","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead","family":"Toomey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan T.","family":"Hennessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"2026073004402115000_21.3.250051.1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2026073004402115000_21.3.250051.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102873"},{"key":"2026073004402115000_21.3.250051.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911793"},{"key":"2026073004402115000_21.3.250051.4","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-1059"},{"key":"2026073004402115000_21.3.250051.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00014009"},{"key":"2026073004402115000_21.3.250051.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00359-2016"},{"key":"2026073004402115000_21.3.250051.7","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.5518"},{"key":"2026073004402115000_21.3.250051.8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jtho.2023.03.027","article-title":"Lung cancer in the Republic of Ireland","volume":"18","author":"Keogh","year":"2023","journal-title":"J Thorac Oncol"},{"key":"2026073004402115000_21.3.250051.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.03.021"},{"key":"2026073004402115000_21.3.250051.10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jtho.2019.12.130","article-title":"Treatment algorithm for advanced ALK-Rearranged NSCLC: a marathon rather than a sprint","volume":"15","author":"Zhou","year":"2020","journal-title":"J Thorac Oncol"},{"key":"2026073004402115000_21.3.250051.11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12885-022-09421-7","article-title":"Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a \u201ctail plateau\u201d in the survival curve of these patients?","volume":"22","author":"Shimamura","year":"2022","journal-title":"BMC Cancer"},{"key":"2026073004402115000_21.3.250051.12","doi-asserted-by":"crossref","first-page":"1611715","DOI":"10.3389\/pore.2024.1611715","article-title":"Targeted therapeutic options in early and metastatic NSCLC-overview","volume":"30","author":"G\u00e1lffy","year":"2024","journal-title":"Pathol Oncol Res"},{"key":"2026073004402115000_21.3.250051.13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/cancers10030072","article-title":"Update on immunohistochemistry for the diagnosis of lung cancer","volume":"10","author":"Inamura","year":"2018","journal-title":"Cancers (Basel)"},{"key":"2026073004402115000_21.3.250051.14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2050-7771-2-3","article-title":"Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine","volume":"2","author":"Hu","year":"2014","journal-title":"Biomark Res"},{"key":"2026073004402115000_21.3.250051.15","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.387"},{"key":"2026073004402115000_21.3.250051.16","first-page":"997","article-title":"Next-generation sequencing technology: current trends and advancements","volume":"12","author":"Satam","year":"2023","journal-title":"Biology (Basel)"},{"key":"2026073004402115000_21.3.250051.17","doi-asserted-by":"crossref","first-page":"230192","DOI":"10.1183\/20734735.0192-2023","article-title":"Unravelling the diagnostic pathology and molecular biomarkers in lung cancer","volume":"20","author":"Charpidou","year":"2024","journal-title":"Breathe (Sheff)"},{"key":"2026073004402115000_21.3.250051.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.12.009"},{"key":"2026073004402115000_21.3.250051.19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jmoldx.2016.08.002","article-title":"Next-generation sequencing in cancer diagnostics","volume":"18","author":"Corless","year":"2016","journal-title":"J Mol Diagn"},{"key":"2026073004402115000_21.3.250051.20","doi-asserted-by":"crossref","first-page":"42478","DOI":"10.18632\/oncotarget.17199","article-title":"Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences","volume":"8","author":"Cho","year":"2017","journal-title":"Oncotarget"},{"key":"2026073004402115000_21.3.250051.21","doi-asserted-by":"crossref","first-page":"152249","DOI":"10.1016\/j.anndiagpath.2023.152249","article-title":"Challenges to the effectiveness of next-generation sequencing in formalin-fixed paraffin-embedded tumor samples for non-small cell lung cancer","volume":"69","author":"da Silveira Corr\u00eaa","year":"2024","journal-title":"Ann Diagn Pathol"},{"key":"2026073004402115000_21.3.250051.22","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/cyt.12974","article-title":"Next generation sequencing in cytology","volume":"32","author":"Pisapia","year":"2021","journal-title":"Cytopathology"},{"key":"2026073004402115000_21.3.250051.23","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1080\/14737159.2021.1985468","article-title":"Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer","volume":"21","author":"Malapelle","year":"2021","journal-title":"Expert Rev Mol Diagn"},{"key":"2026073004402115000_21.3.250051.24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/resp.14680","article-title":"Next-generation sequencing using tissue specimen collected with a 1.1\u2005mm-diameter cryoprobe in patients with lung cancer","volume":"29","author":"Kim","year":"2024","journal-title":"Respirology"},{"key":"2026073004402115000_21.3.250051.25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00408-024-00690-6","article-title":"Endobronchial ultrasound guided transbronchial needle aspiration and next generation sequencing yields","volume":"202","author":"Sheehan","year":"2024","journal-title":"Lung"},{"key":"2026073004402115000_21.3.250051.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102340"},{"key":"2026073004402115000_21.3.250051.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.018"},{"key":"2026073004402115000_21.3.250051.28","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20190866"},{"key":"2026073004402115000_21.3.250051.29","unstructured":"National Cancer Registry Ireland . Cancer in Ireland 1994\u20132020: Annual Statistical Report of the National Cancer Registry. Cork, National Cancer Registry Ireland, 2022. https:\/\/www.ncri.ie\/en\/reports-publications\/reports\/cancer-in-ireland-1994-2020-annual-statistical-report-of-the-national"},{"key":"2026073004402115000_21.3.250051.30","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jtho.2016.03.024","article-title":"Absence of pathological proof of cancer associated with improved outcomes in early-stage lung cancer","volume":"11","author":"Shaikh","year":"2016","journal-title":"J Thorac Oncol"},{"key":"2026073004402115000_21.3.250051.31","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01505-z"},{"key":"2026073004402115000_21.3.250051.32","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.3390\/cancers13163923","article-title":"The liquid biopsy for lung cancer: state of the art, limitations and future developments","volume":"13","author":"Di Capua","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026073004402115000_21.3.250051.33","doi-asserted-by":"crossref","first-page":"103100","DOI":"10.1016\/j.ebiom.2020.103100","article-title":"Challenges and achievements of liquid biopsy technologies employed in early breast cancer","volume":"62","author":"Alba-Bernal","year":"2020","journal-title":"EBioMedicine"},{"key":"2026073004402115000_21.3.250051.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2016.03.006"},{"key":"2026073004402115000_21.3.250051.35","first-page":"e50176","article-title":"Liquid biopsy: an evolving paradigm for non-invasive disease diagnosis and monitoring in medicine","volume":"15","author":"Adhit","year":"2023","journal-title":"Cureus"},{"key":"2026073004402115000_21.3.250051.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-018-0071-5"},{"key":"2026073004402115000_21.3.250051.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2018.06.003"},{"key":"2026073004402115000_21.3.250051.38","doi-asserted-by":"publisher","DOI":"10.1039\/c3lc50644d"},{"key":"2026073004402115000_21.3.250051.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.10.004"},{"key":"2026073004402115000_21.3.250051.40","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3066"},{"key":"2026073004402115000_21.3.250051.41","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2080-8"},{"key":"2026073004402115000_21.3.250051.42","doi-asserted-by":"crossref","first-page":"1326667","DOI":"10.3389\/fimmu.2023.1326667","article-title":"Exosomes in lung cancer metastasis, diagnosis, and immunologically relevant advances","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"},{"key":"2026073004402115000_21.3.250051.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pccm.2023.10.005"},{"key":"2026073004402115000_21.3.250051.44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071611"},{"key":"2026073004402115000_21.3.250051.45","doi-asserted-by":"crossref","first-page":"929677","DOI":"10.3389\/fimmu.2022.929677","article-title":"miR-aculous new avenues for cancer immunotherapy","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"key":"2026073004402115000_21.3.250051.46","doi-asserted-by":"crossref","first-page":"1427724","DOI":"10.3389\/fcell.2024.1427724","article-title":"miR-137: a potential therapeutic target for lung cancer","volume":"12","author":"Liu","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"2026073004402115000_21.3.250051.47","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw037"},{"key":"2026073004402115000_21.3.250051.48","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer: current status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2026073004402115000_21.3.250051.49","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000989"},{"key":"2026073004402115000_21.3.250051.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409405"},{"key":"2026073004402115000_21.3.250051.51","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3390\/diagnostics12081956","article-title":"Low impact of clonal hematopoiesis on the determination of RAS mutations by cell-free DNA testing in routine clinical diagnostics","volume":"12","author":"Roma","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2026073004402115000_21.3.250051.52","doi-asserted-by":"crossref","first-page":"e18700","DOI":"10.1200\/JCO.2021.39.15_suppl.e18700","article-title":"Impact of clonal hematopoiesis to tumor-targeted liquid biopsy in a Chinese pan-cancer cohort","volume":"39","author":"Xu","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026073004402115000_21.3.250051.53","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-0985"},{"key":"2026073004402115000_21.3.250051.54","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0058-3"},{"key":"2026073004402115000_21.3.250051.55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3892\/ol.2011.420","article-title":"Histologic coagulative tumour necrosis as a prognostic indicator of aggressiveness in renal, lung, thyroid and colorectal carcinomas: a brief review","volume":"3","author":"Caruso","year":"2012","journal-title":"Oncol Lett"},{"key":"2026073004402115000_21.3.250051.56","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.2011"},{"key":"2026073004402115000_21.3.250051.57","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-016-9618-0"},{"key":"2026073004402115000_21.3.250051.58","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2353"},{"key":"2026073004402115000_21.3.250051.59","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2696"},{"key":"2026073004402115000_21.3.250051.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bdq.2014.08.001"},{"key":"2026073004402115000_21.3.250051.61","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41591-024-03216-y","article-title":"Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma","volume":"31","author":"Black","year":"2025","journal-title":"Nat Med"},{"key":"2026073004402115000_21.3.250051.62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.25259\/CMAS_02_14_2021","article-title":"Collection and processing of effusion fluids for cytopathologic evaluation","volume":"19","author":"Shidham","year":"2022","journal-title":"Cytojournal"},{"key":"2026073004402115000_21.3.250051.63","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.7150\/thno.34070","article-title":"Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer","volume":"9","author":"Tong","year":"2019","journal-title":"Theranostics"},{"key":"2026073004402115000_21.3.250051.64","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.chest.2023.01.019","article-title":"High yield of pleural cell-free DNA for diagnosis of oncogenic mutations in lung adenocarcinoma","volume":"164","author":"Mahmood","year":"2023","journal-title":"Chest"},{"key":"2026073004402115000_21.3.250051.65","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00660-y"},{"key":"2026073004402115000_21.3.250051.66","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41598-017-00520-1","article-title":"Circulating tumor DNA mutation profiling by targeted next generation sequencing provides guidance for personalized treatments in multiple cancer types","volume":"7","author":"Shu","year":"2017","journal-title":"Sci Rep"},{"key":"2026073004402115000_21.3.250051.67","doi-asserted-by":"crossref","first-page":"100784","DOI":"10.1016\/j.tranon.2020.100784","article-title":"Gene alterations in paired supernatants and precipitates from malignant pleural effusions of non-squamous non-small cell lung cancer","volume":"13","author":"Li","year":"2020","journal-title":"Transl Oncol"},{"key":"2026073004402115000_21.3.250051.68","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/1759-7714.13201","article-title":"Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"Thorac Cancer"},{"key":"2026073004402115000_21.3.250051.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2007.09.001"},{"key":"2026073004402115000_21.3.250051.70","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200707-1136OC"},{"key":"2026073004402115000_21.3.250051.71","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.rmed.2012.06.019","article-title":"Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene","volume":"106","author":"Kordiak","year":"2012","journal-title":"Respir Med"},{"key":"2026073004402115000_21.3.250051.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.04.033"},{"key":"2026073004402115000_21.3.250051.73","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.lungcan.2022.04.013","article-title":"Exhaled breath condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel","volume":"168","author":"Ryan","year":"2022","journal-title":"Lung Cancer"},{"key":"2026073004402115000_21.3.250051.74","doi-asserted-by":"crossref","first-page":"634316","DOI":"10.3389\/fonc.2021.634316","article-title":"The role of liquid biopsy in early diagnosis of lung cancer","volume":"11","author":"Freitas","year":"2021","journal-title":"Front Oncol"},{"key":"2026073004402115000_21.3.250051.75","doi-asserted-by":"crossref","first-page":"462","DOI":"10.21037\/atm-22-1297","article-title":"The utility of sputum supernatant as an alternative liquid biopsy specimen for next-generation sequencing-based somatic variation profiling","volume":"10","author":"Qin","year":"2022","journal-title":"Ann Transl Med"},{"key":"2026073004402115000_21.3.250051.76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12931-022-02097-4","article-title":"Comprehensive characterization reveals sputum supernatant as a valuable alternative liquid biopsy for genome profiling in advanced non-small cell lung cancer","volume":"23","author":"Xie","year":"2022","journal-title":"Respir Res"},{"key":"2026073004402115000_21.3.250051.77","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-019-0220-8"},{"key":"2026073004402115000_21.3.250051.78","doi-asserted-by":"crossref","first-page":"18997","DOI":"10.1038\/s41598-023-39874-0","article-title":"Quantification of rare somatic single nucleotide variants by droplet digital PCR using SuperSelective primers","volume":"13","author":"Pablo-Fontecha","year":"2023","journal-title":"Sci Rep"},{"key":"2026073004402115000_21.3.250051.79","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3663"},{"key":"2026073004402115000_21.3.250051.80","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar3247"},{"key":"2026073004402115000_21.3.250051.81","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00432-021-03648-w","article-title":"Application of circulating genetically abnormal cells in the diagnosis of early-stage lung cancer","volume":"148","author":"Qiu","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"2026073004402115000_21.3.250051.82","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/07357907.2023.2220820","article-title":"The utility of ctDNA in lung cancer clinical research and practice: a systematic review and meta-analysis of clinical studies","volume":"41","author":"Sun","year":"2023","journal-title":"Cancer Invest"},{"key":"2026073004402115000_21.3.250051.83","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s40291-024-00725-x","article-title":"Clinical validity and utility of circulating tumor DNA (ctDNA) testing in advanced non-small cell lung cancer (aNSCLC): a systematic literature review and meta-analysis","volume":"28","author":"Chen","year":"2024","journal-title":"Mol Diagn Ther"},{"key":"2026073004402115000_21.3.250051.84","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jtho.2021.06.017","article-title":"Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer","volume":"16","author":"Rolfo","year":"2021","journal-title":"J Thorac Oncol"},{"key":"2026073004402115000_21.3.250051.85","first-page":"100497","article-title":"Biopsy method and needle size on success of next-generation sequencing in NSCLC: a brief report","volume":"4","author":"Diep","year":"2023","journal-title":"JTO Clin Res Rep"},{"key":"2026073004402115000_21.3.250051.86","doi-asserted-by":"crossref","first-page":"e2300535","DOI":"10.1200\/PO.23.00535","article-title":"Liquid biopsy of lung cancer before pathological diagnosis is associated with shorter time to treatment","volume":"8","author":"Russo","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"2026073004402115000_21.3.250051.87","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0716"},{"key":"2026073004402115000_21.3.250051.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2018.10.002"},{"key":"2026073004402115000_21.3.250051.89","doi-asserted-by":"publisher","DOI":"10.1038\/nature12065"},{"key":"2026073004402115000_21.3.250051.90","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jtho.2023.05.027","article-title":"Longitudinal monitoring of circulating tumor DNA from plasma in patients with curative resected stages I to IIIA EGFR-mutant non-small cell lung cancer","volume":"18","author":"Jung","year":"2023","journal-title":"J Thorac Oncol"},{"key":"2026073004402115000_21.3.250051.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2022.12.001"},{"key":"2026073004402115000_21.3.250051.92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713137"},{"key":"2026073004402115000_21.3.250051.93","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14484"},{"key":"2026073004402115000_21.3.250051.94","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/jcm8070998","article-title":"Liquid biopsy for the detection of resistance mechanisms in NSCLC: comparison of different blood biomarkers","volume":"8","author":"Pasini","year":"2019","journal-title":"J Clin Med"},{"key":"2026073004402115000_21.3.250051.95","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3563"},{"key":"2026073004402115000_21.3.250051.96","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0741"},{"key":"2026073004402115000_21.3.250051.97","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005854"},{"key":"2026073004402115000_21.3.250051.98","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv177"},{"key":"2026073004402115000_21.3.250051.99","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3655"},{"key":"2026073004402115000_21.3.250051.100","first-page":"129","article-title":"Resistance to immune checkpoint inhibitors in KRAS-mutant non-small cell lung cancer","volume":"5","author":"Li","year":"2022","journal-title":"Cancer Drug Resist"},{"key":"2026073004402115000_21.3.250051.101","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2020.01.19"},{"key":"2026073004402115000_21.3.250051.102","doi-asserted-by":"crossref","first-page":"S983","DOI":"10.1016\/j.annonc.2021.08.1856","article-title":"1252P Liquid biopsy to track KRAS G12C mutation at progressive disease in patients with advanced non-small cell lung cancer (NSCLC)","volume":"32","author":"De Renzi","year":"2021","journal-title":"Ann Oncol"},{"key":"2026073004402115000_21.3.250051.103","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.21037\/tlcr.2019.10.22","article-title":"Targeting BRAF mutations in non-small cell lung cancer","volume":"8","author":"O'Leary","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"2026073004402115000_21.3.250051.104","first-page":"e15136","article-title":"A rare case of small cell lung cancer with an epidermal growth factor receptor mutation and its response to osimertinib","volume":"13","author":"Bhuiyan","year":"2021","journal-title":"Cureus"},{"key":"2026073004402115000_21.3.250051.105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/cimb47010066","article-title":"A case of non-small cell lung cancer with mutually exclusive EGFR and KRAS mutations","volume":"47","author":"Tushir","year":"2025","journal-title":"Curr Issues Mol Biol"},{"key":"2026073004402115000_21.3.250051.106","first-page":"100725","article-title":"Liquid biopsy in the management of advanced lung cancer: implementation and practical aspects","volume":"36","author":"Fernandes","year":"2023","journal-title":"Cancer Treat Res Commun"},{"key":"2026073004402115000_21.3.250051.107","doi-asserted-by":"publisher","DOI":"10.1038\/nature22364"},{"key":"2026073004402115000_21.3.250051.108","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3519"},{"key":"2026073004402115000_21.3.250051.109","doi-asserted-by":"crossref","first-page":"S820","DOI":"10.21037\/jtd.2018.04.09","article-title":"Comprehensive targeted super-deep next generation sequencing enhances differential diagnosis of solitary pulmonary nodules","volume":"10","author":"Ye","year":"2018","journal-title":"J Thorac Dis"},{"key":"2026073004402115000_21.3.250051.110","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jtho.2017.05.022","article-title":"Application of plasma genotyping technologies in non\u2013small cell lung cancer: a practical review","volume":"12","author":"Sacher","year":"2017","journal-title":"J Thorac Oncol"},{"key":"2026073004402115000_21.3.250051.111","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.3390\/cancers15215198","article-title":"Adding value to liquid biopsy for brain tumors: the role of imaging","volume":"15","author":"Khalili","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026073004402115000_21.3.250051.112","first-page":"123","article-title":"Emerging significance and clinical application of liquid biopsy in early diagnosis and monitoring of cancer","volume":"51","author":"Ghagane","year":"2024","journal-title":"J Sci Soc"},{"key":"2026073004402115000_21.3.250051.113","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/10408363.2023.2230290","article-title":"Pre-analytical conditions and implementation of quality control steps in liquid biopsy analysis","volume":"60","author":"Ntzifa","year":"2023","journal-title":"Crit Rev Clin Lab Sci"},{"key":"2026073004402115000_21.3.250051.114","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13046-024-03026-7","article-title":"Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation","volume":"43","author":"Ren","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"2026073004402115000_21.3.250051.115","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-9000"},{"key":"2026073004402115000_21.3.250051.116","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1007\/s10147-021-01947-3","article-title":"CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M\u2013positive lung cancer after osimertinib","volume":"26","author":"Kato","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"2026073004402115000_21.3.250051.117","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf2341"},{"key":"2026073004402115000_21.3.250051.118","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.02.011"},{"key":"2026073004402115000_21.3.250051.119","doi-asserted-by":"crossref","first-page":"64","DOI":"10.21037\/atm-23-1572","article-title":"Circulating tumour DNA analysis for early detection of lung cancer: a systematic review","volume":"12","author":"Lam","year":"2024","journal-title":"Ann Transl Med"},{"key":"2026073004402115000_21.3.250051.120","doi-asserted-by":"crossref","first-page":"856575","DOI":"10.3389\/fonc.2022.856575","article-title":"Liquid biopsy and artificial intelligence as tools to detect signatures of colorectal malignancies: a modern approach in patient's stratification","volume":"12","author":"Ginghina","year":"2022","journal-title":"Front Oncol"},{"key":"2026073004402115000_21.3.250051.121","doi-asserted-by":"publisher","DOI":"10.1111\/cas.16097"},{"key":"2026073004402115000_21.3.250051.122","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.7"},{"key":"2026073004402115000_21.3.250051.123","doi-asserted-by":"crossref","first-page":"100146","DOI":"10.1016\/j.jlb.2024.100146","article-title":"Liquid biopsy into the clinics: current evidence and future perspectives","volume":"4","author":"Boukovala","year":"2024","journal-title":"J Liq Biopsy"}],"container-title":["Breathe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/20734735.0051-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:40:37Z","timestamp":1785411637000},"score":1,"resource":{"primary":{"URL":"http:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/20734735.0051-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":123,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,19]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1183\/20734735.0051-2025"],"URL":"https:\/\/doi.org\/10.1183\/20734735.0051-2025","relation":{},"ISSN":["1810-6838","2073-4735"],"issn-type":[{"value":"1810-6838","type":"print"},{"value":"2073-4735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}